Comparing cisplatin-Chemoradiotherapy to Cetuximab-radiotherapy in HPV(+) “low-risk” locally advanced oropharyngeal squamous cell carcinoma: lessons from De-escalate study

BACKGROUND: Human papillomavirus-associated oropharyngeal cancer (HPV-OSCC) is rapidly increasing in incidence and has unique epidemiologic, molecular, and biologic characteristics. Standard combined modality therapies for head and neck cancer confer a significant risk of morbidity. However, patient...

Descripción completa

Detalles Bibliográficos
Autores principales: Economopoulou, Panagiota, Psyrri, Amanda
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460733/
https://www.ncbi.nlm.nih.gov/pubmed/31093366
http://dx.doi.org/10.1186/s41199-019-0040-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6460733/
https://www.ncbi.nlm.nih.gov/pubmed/31093366
http://dx.doi.org/10.1186/s41199-019-0040-5

Ejemplares similares